Literature DB >> 8090713

1.56 A structure of mature truncated human fibroblast collagenase.

J C Spurlino1, A M Smallwood, D D Carlton, T M Banks, K J Vavra, J S Johnson, E R Cook, J Falvo, R C Wahl, T A Pulvino.   

Abstract

The X-ray crystal structure of a 19 kDa active fragment of human fibroblast collagenase has been determined by the multiple isomorphous replacement method and refined at 1.56 A resolution to an R-factor of 17.4%. The current structure includes a bound hydroxamate inhibitor, 88 waters and three metal atoms (two zincs and a calcium). The overall topology of the enzyme, comprised of a five stranded beta-sheet and three alpha-helices, is similar to the thermolysin-like metalloproteinases. There are some important differences between the collagenase and thermolysin families of enzymes. The active site zinc ligands are all histidines (His-218, His-222, and His-228). The presence of a second zinc ion in a structural role is a unique feature of the matrix metalloproteinases. The binding properties of the active site cleft are more dependent on the main chain conformation of the enzyme (and substrate) compared with thermolysin. A mechanism of action for peptide cleavage similar to that of thermolysin is proposed for fibroblast collagenase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8090713     DOI: 10.1002/prot.340190203

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  23 in total

1.  Dynamics of stromelysin/inhibitor interactions studied by 15N NMR relaxation measurements: comparison of ligand binding to the S1-S3 and S'1-S'3 subsites.

Authors:  P Yuan; V P Marshall; G L Petzold; R A Poorman; B J Stockman
Journal:  J Biomol NMR       Date:  1999-09       Impact factor: 2.835

Review 2.  Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.

Authors:  Klaus Maskos; Wolfram Bode
Journal:  Mol Biotechnol       Date:  2003-11       Impact factor: 2.695

3.  Methanethiol Binding Strengths and Deprotonation Energies in Zn(II)-Imidazole Complexes from M05-2X and MP2 Theories: Coordination Number and Geometry Influences Relevant to Zinc Enzymes.

Authors:  Douglas P Linder; Kenton R Rodgers
Journal:  J Phys Chem B       Date:  2015-09-04       Impact factor: 2.991

4.  Binary image representation of a ligand binding site: its application to efficient sampling of a conformational ensemble.

Authors:  Edon Sung; Sangsoo Kim; Whanchul Shin
Journal:  BMC Bioinformatics       Date:  2010-05-18       Impact factor: 3.169

5.  Calcium regulates tertiary structure and enzymatic activity of human endometase/matrilysin-2 and its role in promoting human breast cancer cell invasion.

Authors:  Seakwoo Lee; Hyun I Park; Qing-Xiang Amy Sang
Journal:  Biochem J       Date:  2007-04-01       Impact factor: 3.857

6.  Structural characterizations of nonpeptidic thiadiazole inhibitors of matrix metalloproteinases reveal the basis for stromelysin selectivity.

Authors:  B C Finzel; E T Baldwin; G L Bryant; G F Hess; J W Wilks; C M Trepod; J E Mott; V P Marshall; G L Petzold; R A Poorman; T J O'Sullivan; H J Schostarez; M A Mitchell
Journal:  Protein Sci       Date:  1998-10       Impact factor: 6.725

7.  Structure of malonic acid-based inhibitors bound to human neutrophil collagenase. A new binding mode explains apparently anomalous data.

Authors:  H Brandstetter; R A Engh; E G Von Roedern; L Moroder; R Huber; W Bode; F Grams
Journal:  Protein Sci       Date:  1998-06       Impact factor: 6.725

8.  QXP: powerful, rapid computer algorithms for structure-based drug design.

Authors:  C McMartin; R S Bohacek
Journal:  J Comput Aided Mol Des       Date:  1997-07       Impact factor: 3.686

9.  Comparison of the structure of human recombinant short form stromelysin by multidimensional heteronuclear NMR and X-ray crystallography.

Authors:  P R Gooley; J F O'Connell; A I Marcy; G C Cuca; M G Axel; C G Caldwell; W K Hagmann; J W Becker
Journal:  J Biomol NMR       Date:  1996-01       Impact factor: 2.835

10.  Solution structures of stromelysin complexed to thiadiazole inhibitors.

Authors:  B J Stockman; D J Waldon; J A Gates; T A Scahill; D A Kloosterman; S A Mizsak; E J Jacobsen; K L Belonga; M A Mitchell; B Mao; J D Petke; L Goodman; E A Powers; S R Ledbetter; P S Kaytes; G Vogeli; V P Marshall; G L Petzold; R A Poorman
Journal:  Protein Sci       Date:  1998-11       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.